Effect of rabeprazole and sucralfate on low-dose aspirin-related gastroduodenal mucosal injury

Effect of rabeprazole and sucralfate on low-dose aspirin-related gastroduodenal mucosal injury - Effect of rabeprazole and sucralfate on low-dose aspirin-related gastroduodenal mucosal injury

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001679

Enrollment

Registered

2009-02-02

Start date

2009-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients having taken low-dose aspirin

Interventions

rabeprazole 10mg/day, 4 weeks sucralfate 3g/day, 4 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have taken low-dose aspirin regularly

Exclusion criteria

Exclusion criteria: 1.below 20 years of age 2.contraindication against rabeprazole and sucralfate 3.malignancy 4.pregnancy

Design outcomes

Primary

Measure	Time frame
Improvement of endoscopic finding before and 4 weeks after initiating rabeprazole or sucralfate	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026